Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease

Jie Lu, Grégoire P. Chatain, Alejandro Bugarini, Xiang Wang, Dragan Maric, Stuart Walbridge, Zhengping Zhuang, Prashant Chittiboina

The Journal of Clinical Endocrinology & Metabolism · 2017 · 63 citations · 31 references

DOIFull text

Open access

Abstract

Our findings demonstrate SAHA's efficacy in reducing survival and ACTH secretion in AtT-20 and hCtT cells, providing a potential intervention for recurrent/unremitting CD.

References

31